Compare Novavax Inc (NVAX) vs Global X Defense Tech ETF (SHLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Global X Defense Tech ETF — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Global X Defense Tech ETF trades at $60.24. The key difference: Novavax Inc is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| NVAX | SHLD | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Sector/Thematic |
52-Week High | $11.19 | $78.02 |
52-Week Low | $6.22 | $58.20 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →
